Frost Radar™: Soft Tissue Navigation Systems, 2023

Frost Radar™: Soft Tissue Navigation Systems, 2023

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

RELEASE DATE
27-Jun-2023
REGION
Global
Deliverable Type
Frost Radar
Research Code: K907-01-00-00-00
SKU: HC03681-GL-MR_27816
AvailableYesPDF Download

$4,950.00

Special Price $4,455.00 save 10 %

In stock
SKU
HC03681-GL-MR_27816

Frost Radar™: Soft Tissue Navigation Systems, 2023
Published on: 27-Jun-2023 | SKU: HC03681-GL-MR_27816

Need more details?

$4,950.00

$4,455.00save 10 %

DownloadLink
Need more details?

Robot-assisted surgery offers significant promise in driving down treatment costs and addressing the healthcare industry’s increasing burden of lifestyle-related diseases and demand for affordable care. Next-generation surgical robotics technology and surgical navigation systems complement and extend surgeons’ ability to minimize surgical variability, a key factor driving the adoption of surgical navigation systems platforms among hospitals, as now surgeons can perform complex tasks with greater control and less strain while ensuring patient safety.

With the advancement of digital and analytical technologies, deployment of artificial intelligence (AI) technologies, including machine learning and machine vision, in next-generation surgical platforms enables the systems to offer insights to surgeons based on analysis of the data collected. Moreover, haptic feedback signals when the pressure threshold is reached to prevent damaging anatomical structures. Flexible payment and leasing business models, improved ergonomics, multi-quadrant surgeries, reduced surgeon burnout, and occupation-related disease acquisition are key trends in this area. Frost & Sullivan expects the adoption of next-generation surgical navigation technology platforms to increase inpatient surgery volumes by reducing patients’ length of stay (LOS) and offer significant cost advantages for hospitals.

In a field of about 25 industry participants, this Frost Radar™ analysis highlights the top 11 companies that generated revenue from soft tissue surgical navigation systems between 2019 and 2022. These industry participants actively market, install, and develop surgical navigation platforms. Frost & Sullivan analyzes numerous companies in an industry. Those selected for further analysis based on their leadership or other distinctions are benchmarked across 10 Growth and Innovation criteria to reveal their position on the Frost Radar™. The publication presents competitive profiles of each company on the Frost Radar™, considering their strengths and the opportunities that best fit those strengths.

Soft Tissue Navigation Systems 2023

  • Soft Tissue Navigation Systems
Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

Robot-assisted surgery offers significant promise in driving down treatment costs and addressing the healthcare industry’s increasing burden of lifestyle-related diseases and demand for affordable care. Next-generation surgical robotics technology and surgical navigation systems complement and extend surgeons’ ability to minimize surgical variability, a key factor driving the adoption of surgical navigation systems platforms among hospitals, as now surgeons can perform complex tasks with greater control and less strain while ensuring patient safety. With the advancement of digital and analytical technologies, deployment of artificial intelligence (AI) technologies, including machine learning and machine vision, in next-generation surgical platforms enables the systems to offer insights to surgeons based on analysis of the data collected. Moreover, haptic feedback signals when the pressure threshold is reached to prevent damaging anatomical structures. Flexible payment and leasing business models, improved ergonomics, multi-quadrant surgeries, reduced surgeon burnout, and occupation-related disease acquisition are key trends in this area. Frost & Sullivan expects the adoption of next-generation surgical navigation technology platforms to increase inpatient surgery volumes by reducing patients’ length of stay (LOS) and offer significant cost advantages for hospitals. In a field of about 25 industry participants, this Frost Radar™ analysis highlights the top 11 companies that generated revenue from soft tissue surgical navigation systems between 2019 and 2022. These industry participants actively market, install, and develop surgical navigation platforms. Frost & Sullivan analyzes numerous companies in an industry. Those selected for further analysis based on their leadership or other distinctions are benchmarked across 10 Growth and Innovation criteria to reveal their position on the Frost Radar™. The publication presents competitive profiles of each company on the Frost Radar™, considering their strengths and the opportunities that best fit those strengths.
More Information
Deliverable Type Frost Radar
Industries Healthcare
No Index No
Is Prebook No
Keyword 1 Surgical Navigation Systems
Keyword 2 Soft Tissue Navigation
Keyword 3 Soft tissue monitoring
Podcast No
WIP Number K907-01-00-00-00